bibliographic entry 1648648 [be/1648648]
https://w3id.org/oc/corpus/be/1648648

is a

• bibliographic reference

content

• Bedard, P. L, Tabernero, J, Janku, F, Wainberg, Z. A, Paz-Ares, L, Vansteenkiste, J. (2015). A phase Ib dose-escalation study of the oral pan-PI3K inhibitor buparlisib (BKM120) in combination with the oral MEK1/2 inhibitor trametinib (GSK1120212) in patients with selected advanced solid tumors. Clin. Cancer Res. 21, 730–738. DOI: 10.1158/1078-0432.CCR-14-1814 PMID: 25500057

references

• https://w3id.org/oc/corpus/br/758324